SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-046862
Filing Date
2022-12-23
Accepted
2022-12-23 16:15:13
Documents
13
Period of Report
2022-12-20
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10045758_8k.htm   iXBRL 8-K 35999
2 EXHIBIT 99.1 brhc10045758_ex99-1.htm EX-99.1 6282
  Complete submission text file 0001140361-22-046862.txt   187170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20221220.xsd EX-101.SCH 3869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20221220_lab.xml EX-101.LAB 23291
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20221220_pre.xml EX-101.PRE 16555
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10045758_8k_htm.xml XML 4382
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 221485539
SIC: 2834 Pharmaceutical Preparations